AquaBounty Technologies, Inc. AquaBounty has been formally
seeking regulatory approval with the US Food and Drug
Administration (USFDA) to commercialize growth hormone (GH)
transgenic Atlantic salmon (trade name: Aquadvantage Salmon)
as an aquaculture product for nearly 20 years (US Food Drug
Admin, 2012)